Sermorelin
Native GHRH(1-29) fragment that has the most clinical history of all GHRH peptides. Studied extensively for age-related GH decline and HPA axis normalisation.
Buy more, save more
Total Price
$50
For research & laboratory use only. Not for human consumption.
Half-Life
~7-12 minutes
Administration Route
Subcutaneous injection
Natural GHRH Sequence
First 29 amino acids of endogenous growth hormone-releasing hormone
Hypothalamic Feedback
Preserves natural GH axis; avoids pituitary suppression
Anti-Aging HGH
Restores youthful GH output in age-related decline
Effect Profile
Muscle Growth
Fat Oxidation
Recovery Speed
Strength
Mechanism of Action
Scientific Research
Endocr Rev (1997)
J Clin Endocrinol Metab (1996)
Endocr Rev (1997)
Product FAQs
Stacks Well With
Ipamorelin
Highly selective growth hormone secretagogue with minimal cortisol or prolactin stimulation, offering clean GH pulses for muscle growth, recovery, and body
GHRP-2
Second-generation GHRP with potent GH-releasing activity and mild ghrelin-like effects on appetite, studied for GH deficiency, muscle preservation, and
GHRP-6
First-generation GHRP with potent GH-releasing activity and strong appetite stimulation, widely used in research for GH axis studies and muscle wasting models.
Related Products
CJC-1295 without DAC
Modified GHRH fragment (Mod GRF 1-29) that produces acute, physiological GH pulses when combined with a GHRP. The standard pairing with ipamorelin for clean GH
Ipamorelin
Highly selective growth hormone secretagogue with minimal cortisol or prolactin stimulation, offering clean GH pulses for muscle growth, recovery, and body
Tesamorelin
FDA-approved GHRH analogue (Egrifta) for HIV-associated visceral fat reduction. The most clinically validated GHRH peptide for abdominal fat mobilisation and
GHRP-2
Second-generation GHRP with potent GH-releasing activity and mild ghrelin-like effects on appetite, studied for GH deficiency, muscle preservation, and